Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.

Bortnik M, Degiovanni A, Dell'era G, Cavallino C, Occhetta E, Marino P.

J Cardiovasc Med (Hagerstown). 2014 Apr;15(4):301-6. doi: 10.2459/JCM.0b013e3283638148.

PMID:
23811840
2.

Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.

Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W.

Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.

3.

Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.

Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64. doi: 10.1161/CIRCEP.112.000214. Epub 2013 Feb 26.

4.

Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.

Thijssen J, Borleffs CJ, Delgado V, van Rees JB, Mooyaart EA, van Bommel RJ, van Erven L, Boersma E, Bax JJ, Schalij MJ.

J Am Coll Cardiol. 2011 Nov 22;58(22):2282-9. doi: 10.1016/j.jacc.2011.08.038.

5.
6.

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.

Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS.

Circ Arrhythm Electrophysiol. 2017 Mar;10(3). pii: e004875. doi: 10.1161/CIRCEP.116.004875.

PMID:
28292754
7.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

8.

Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.

Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.

Europace. 2012 Feb;14(2):224-9. doi: 10.1093/europace/eur307. Epub 2011 Sep 22.

PMID:
21946820
9.

Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.

Davis DR, Krahn AD, Tang AS, Lemery R, Green MS, Gollob M, Yee R, Skanes AC, Klein GJ, Birnie DH.

Can J Cardiol. 2005 Apr;21(5):413-7.

PMID:
15861258
10.

Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.

Hua W, Chen K, Zhou X, Dai Y, Chen R, Wang J, Ding L, Liu Z, Feng T, Yu J, Cheng J, Liu C, Zhang S.

Europace. 2015 Feb;17(2):281-8. doi: 10.1093/europace/euu258. Epub 2014 Nov 14.

PMID:
25398405
11.

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.

Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.

Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.

PMID:
18952828
12.

Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.

Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659. Epub 2009 Nov 18.

PMID:
20102900
13.

Outcome of patients with cardiac resynchronisation defibrillator therapy and a follow-up of at least five years after implant.

Bossard M, Sticherling C, Kühne M, Frey S, Osswald S, Schaer B.

Swiss Med Wkly. 2014 Feb 26;144:w13938. doi: 10.4414/smw.2014.13938.

14.

Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).

Lee AY, Moss AJ, Ruwald MH, Kutyifa V, McNitt S, Polonsky B, Zareba W, Ruwald AC.

Am J Cardiol. 2015 May 15;115(10):1423-7. doi: 10.1016/j.amjcard.2015.02.029. Epub 2015 Feb 18.

PMID:
25817576
15.

Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy.

Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):762-72. doi: 10.1161/CIRCEP.112.971101. Epub 2012 Jul 11.

16.

Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).

Gold MR, Daubert JC, Abraham WT, Hassager C, Dinerman JL, Hudnall JH, Cerkvenik J, Linde C.

Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1163-8. doi: 10.1161/CIRCEP.113.000570. Epub 2013 Oct 14.

17.

Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.

Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF.

Ann Intern Med. 2014 May 6;160(9):603-11. doi: 10.7326/M13-1879.

PMID:
24798523
18.

Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.

Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.

19.

Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.

Lenarczyk R, Kowalski O, Sredniawa B, Pruszkowska-Skrzep P, Mazurek M, Jędrzejczyk-Patej E, Woźniak A, Pluta S, Głowacki J, Kalarus Z.

J Cardiovasc Electrophysiol. 2012 Nov;23(11):1228-36. doi: 10.1111/j.1540-8167.2012.02375.x. Epub 2012 May 31.

PMID:
22651239
20.

Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.

Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.

J Am Coll Cardiol. 2005 Dec 20;46(12):2258-63.

Supplemental Content

Support Center